ViS
New York · Founded 2010
About ViS
ViS provides a game-changing analytics platform for the planning of clinical trials. Pharmaceutical trials are required for the evaluation of new medicines, and ViS' collaborative analytics radically improves cost-efficiency in the selection of research centers for trial participation. ViS provides the only interactive map of global clinical research infrastructure, which achieves two objectives: I) allows trial planners to quickly find centers and make sense of vast amounts of comparative multi-dimensional analytics, going easily from the country level down to that of the center; and II) enables the more than 400,000 globally distributed research centers to securely and efficiently showcase their technical disease-specific capabilities to trial planners, while also connecting with collaborating centers that can lead to future projects.
Company Facts
- Founded: 2010
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $1.5M
- Funding stage: Seed
- Last round: Angel (Aug 2012)
- Website: visresearch.org
- Phone: 646-783-9154
Social Profiles
Canonical: https://fsome.com/organization/vis-8280047 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.